Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

GSK blames political and regulatory pressures for the decline in its vaccine’s business in 2024, as it expects sales to further shrink in 2025. Despite these challenges, GSK beat Q4 2024 ...

Warren asked him to pledge not to receive any compensation from lawsuits against pharma companies as HHS secretary and four ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...

GlaxoSmithKline and Merck (MSD outside of the US and Canada) have both been awarded a significant portion of the UNICEF HPV vaccine tender in order to provide the vaccinations. GSK is to provide a ...

RAHWAY, N.J., February 06, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada ... reports robust sales growth driven by KEYTRUDA and WINREVAIR, while navigating GARDASIL ...